 gamma-Aminobutyric Acid
"gamma-Aminobutyric Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The most common inhibitory neurotransmitter in the central nervous system.
| Descriptor ID |
D005680
|
| MeSH Number(s) |
D02.241.081.114.500.350 D12.125.190.350
|
| Concept/Terms |
gamma-Aminobutyric Acid- gamma-Aminobutyric Acid
- gamma Aminobutyric Acid
- GABA
- Aminalon
- Aminalone
- 4-Aminobutanoic Acid
- 4 Aminobutanoic Acid
- 4-Aminobutyric Acid
- 4 Aminobutyric Acid
|
Below are MeSH descriptors whose meaning is more general than "gamma-Aminobutyric Acid".
Below are MeSH descriptors whose meaning is more specific than "gamma-Aminobutyric Acid".
This graph shows the total number of publications written about "gamma-Aminobutyric Acid" by people in UAMS Profiles by year, and whether "gamma-Aminobutyric Acid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 1 | 1 | 2 | | 2019 | 1 | 0 | 1 | | 2018 | 2 | 0 | 2 | | 2017 | 1 | 1 | 2 | | 2016 | 1 | 1 | 2 | | 2015 | 4 | 1 | 5 | | 2014 | 1 | 1 | 2 | | 2013 | 4 | 2 | 6 | | 2012 | 1 | 0 | 1 | | 2011 | 3 | 2 | 5 | | 2010 | 4 | 0 | 4 | | 2009 | 3 | 2 | 5 | | 2008 | 0 | 2 | 2 | | 2007 | 2 | 2 | 4 | | 2006 | 1 | 1 | 2 | | 2005 | 1 | 0 | 1 | | 2003 | 2 | 0 | 2 | | 2002 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 2000 | 1 | 0 | 1 | | 1999 | 1 | 1 | 2 | | 1997 | 1 | 0 | 1 | | 1996 | 2 | 0 | 2 | | 1995 | 0 | 1 | 1 | | 1994 | 1 | 1 | 2 | | 1992 | 0 | 1 | 1 | | 1991 | 1 | 0 | 1 | | 1987 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "gamma-Aminobutyric Acid" by people in Profiles over the past ten years.
-
Park GH, Noh H, Shao Z, Ni P, Qin Y, Liu D, Beaudreault CP, Park JS, Abani CP, Park JM, Le DT, Gonzalez SZ, Guan Y, Cohen BM, McPhie DL, Coyle JT, Lanz TA, Xi HS, Yin C, Huang W, Kim HY, Chung S. Activated microglia cause metabolic disruptions in developmental cortical interneurons that persist in interneurons from individuals with schizophrenia. Nat Neurosci. 2020 11; 23(11):1352-1364.
-
Graves JM, Dilley J, Kubsad S, Liebelt E. Notes from the Field: Phenibut Exposures Reported to Poison Centers - United States, 2009-2019. MMWR Morb Mortal Wkly Rep. 2020 09 04; 69(35):1227-1228.
-
Krishnamurthy LC, Krishnamurthy V, Crosson B, Rothman DL, Schwam DM, Greenberg D, Pugh KR, Morris RD. Strength of resting state functional connectivity and local GABA concentrations predict oral reading of real and pseudo-words. Sci Rep. 2019 08 06; 9(1):11385.
-
Perissinotti PP, Rivero-Echeto MC, Garcia-Rill E, Bisagno V, Urbano FJ. Leptin alters somatosensory thalamic networks by decreasing gaba release from reticular thalamic nucleus and action potential frequency at ventrobasal neurons. Brain Struct Funct. 2018 Jun; 223(5):2499-2514.
-
Kang YJ, Lewis HES, Young MW, Govindaiah G, Greenfield LJ, Garcia-Rill E, Lee SH. Cell Type-specific Intrinsic Perithreshold Oscillations in Hippocampal GABAergic Interneurons. Neuroscience. 2018 04 15; 376:80-93.
-
Crowe MS, Wilson CD, Leishman E, Prather PL, Bradshaw HB, Banks ML, Kinsey SG. The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice. Br J Pharmacol. 2017 Dec; 174(23):4523-4539.
-
Lee HG, Grossman SK, Valdes-Rodriguez R, Berenato F, Korbutov J, Chan YH, Lavery MJ, Yosipovitch G. Topical ketamine-amitriptyline-lidocaine for chronic pruritus: A retrospective study assessing efficacy and tolerability. J Am Acad Dermatol. 2017 04; 76(4):760-761.
-
Lee SH, Dudok B, Parihar VK, Jung KM, Zöldi M, Kang YJ, Maroso M, Alexander AL, Nelson GA, Piomelli D, Katona I, Limoli CL, Soltesz I. Neurophysiology of space travel: energetic solar particles cause cell type-specific plasticity of neurotransmission. Brain Struct Funct. 2017 Jul; 222(5):2345-2357.
-
Armstrong C, Wang J, Yeun Lee S, Broderick J, Bezaire MJ, Lee SH, Soltesz I. Target-selectivity of parvalbumin-positive interneurons in layer II of medial entorhinal cortex in normal and epileptic animals. Hippocampus. 2016 06; 26(6):779-93.
-
Goitia B, Rivero-Echeto MC, Weisstaub NV, Gingrich JA, Garcia-Rill E, Bisagno V, Urbano FJ. Modulation of GABA release from the thalamic reticular nucleus by cocaine and caffeine: role of serotonin receptors. J Neurochem. 2016 Feb; 136(3):526-35.
-
Light KE, Hayar AM, Pierce DR. Electrophysiological and Immunohistochemical Evidence for an Increase in GABAergic Inputs and HCN Channels in Purkinje Cells that Survive Developmental Ethanol Exposure. Cerebellum. 2015 Aug; 14(4):398-412.
-
Lee SH, Ledri M, Tóth B, Marchionni I, Henstridge CM, Dudok B, Kenesei K, Barna L, Szabó SI, Renkecz T, Oberoi M, Watanabe M, Limoli CL, Horvai G, Soltesz I, Katona I. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release. J Neurosci. 2015 Jul 08; 35(27):10039-57.
-
Ehrlich DE, Neigh GN, Bourke CH, Nemeth CL, Hazra R, Ryan SJ, Rowson S, Jairam N, Sholar CA, Rainnie DG, Stowe ZN, Owens MJ. Prenatal stress, regardless of concurrent escitalopram treatment, alters behavior and amygdala gene expression of adolescent female rats. Neuropharmacology. 2015 Oct; 97:251-8.
-
Wei LA, Davies BW, Hink EM, Durairaj VD. Perioperative pregabalin for attenuation of postoperative pain after eyelid surgery. Ophthalmic Plast Reconstr Surg. 2015 Mar-Apr; 31(2):132-5.
-
Dudok B, Barna L, Ledri M, Szabó SI, Szabadits E, Pintér B, Woodhams SG, Henstridge CM, Balla GY, Nyilas R, Varga C, Lee SH, Matolcsi M, Cervenak J, Kacskovics I, Watanabe M, Sagheddu C, Melis M, Pistis M, Soltesz I, Katona I. Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nat Neurosci. 2015 Jan; 18(1):75-86.
-
Mancino MJ, McGaugh J, Chopra MP, Guise JB, Cargile C, Williams DK, Thostenson J, Kosten TR, Sanders N, Oliveto A. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms. J Clin Psychopharmacol. 2014 Apr; 34(2):234-9.
-
Sanders NC, Mancino MJ, Gentry WB, Guise JB, Bickel WK, Thostenson J, Oliveto AH. Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure. Exp Clin Psychopharmacol. 2013 Aug; 21(4):294-302.
-
Wielage R, Bansal M, Wilson K, Klein R, Happich M. Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective. Spine (Phila Pa 1976). 2013 May 15; 38(11):936-46.
-
Brady RO, McCarthy JM, Prescot AP, Jensen JE, Cooper AJ, Cohen BM, Renshaw PF, Ongür D. Brain gamma-aminobutyric acid (GABA) abnormalities in bipolar disorder. Bipolar Disord. 2013 Jun; 15(4):434-9.
-
Blau GE, Orcun S, Laínez JM, Reklaitis GV, Suvannasankha A, Fausel C, Anaissie EJ. Validation of a novel approach for dose individualization in pharmacotherapy using gabapentin in a proof of principles study. Pharmacotherapy. 2013 Jul; 33(7):727-35.
-
Ivakine EA, Acton BA, Mahadevan V, Ormond J, Tang M, Pressey JC, Huang MY, Ng D, Delpire E, Salter MW, Woodin MA, McInnes RR. Neto2 is a KCC2 interacting protein required for neuronal Cl- regulation in hippocampal neurons. Proc Natl Acad Sci U S A. 2013 Feb 26; 110(9):3561-6.
-
Goitia B, Raineri M, González LE, Rozas JL, Garcia-Rill E, Bisagno V, Urbano FJ. Differential effects of methylphenidate and cocaine on GABA transmission in sensory thalamic nuclei. J Neurochem. 2013 Mar; 124(5):602-12.
-
Garcia-Rill E, Kezunovic N, Hyde J, Simon C, Beck P, Urbano FJ. Coherence and frequency in the reticular activating system (RAS). Sleep Med Rev. 2013 Jun; 17(3):227-38.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|